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Abstract
Background: To explore any gender-related differences in the prevalence of conditions-associated with non-
alcoholic fatty liver disease (NAFLD) among Taiwanese taxi drivers in Taipei, Taiwan.
Methods: We studied 1635 healthy taxi drivers (1541 males and 94 females) who volunteered for physical check-
ups in 2006. Blood samples and ultrasound fatty liver sonography results were collected.
Results: The prevalence of NAFLD was 66.4% and revealed no statistically significant decrease with increasing age
(p = 0.58). Males exhibited a greater prevalence of NAFLD than did females (67.5% vs 47.9%, p < 0.0001). Gender-
related differences for associated factors were found. For males, hypertension, hyperuricemia, higher AST, higher
ALT, hypertriglyceridemia, and higher fasting plasma glucose were significantly related to NAFLD. These conditions
were not sigfinicantly related to NAFLD in females.
Conclusion: Several gender-related differences were noted for NAFLD among Taiwanese taxi drivers.
Keywords: nonalcoholic fatty liver disease, prevalence, taxi drivers, gender difference
Background
Non-alcoholic fatty liver disease (NAFLD) is a clinic-
pathological diagnosis characterized by macrovesicular
steatosis in hepatocytes and metabolic stress-related
liver disorder, occurring in the absence of other causes
of chronic liver disease [1]. It includes a wide spectrum
of liver diseases, ranging from pure fatty liver disease,
which is usually a benign and nonprogressive condition,
to nonalcoholic steatohepatitis (NASH), which may
eventually progress to liver cirrhosis, portal hyperten-
sion, and hepatocellular carcinoma [2]. Epidemiological
studies of fatty liver disease showed some important risk
factors. In China, along with the improved living stan-
dard and increased alcohol consumption, population-
based surveys have revealed that fatty liver has become
a serious public health problem [3,4]. In addition, the
steadily increasing morbidity of obesity, coupled with
type 2 diabetes, dyslipidemia, hypertension, and ulti-
mately the metabolic syndrome has also put a large pro-
portion of the Chinese population at risk[5]. From the
preventive medicine viewpoint, early detection of this
liver disorder by screening followed by appropriate
intervention may offer a practical means for the preven-
tion of condition-associated hepatocellular damage.
In Taiwan, the “taxi” industry is a lightly restricted
vocational. A person can be a taxi driver if he or she
has an occupational driver’s license, practice registration,
and a taxi car. It is often the choice of people with a
lower education and a lack of economic, social, or
human capital. A survey revealed that more than 90% of
taxi drivers were male, 70% were between 40 and 59
years of age, and 50% had a junior high school educa-
tion or below. The average working time was 10.3 hours
a day, 6.2 days a week. They spent 3.5 hours waiting for
passengers. Due to their being alienated from a work-
place environment, repetition, monotony, boredom, a
low sense of control over their work, and the stress of
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physical and mental health risks.
To the best of our knowledge, few studies have
explored the epidemiologic information of NAFLD
among taxi drivers in Taiwan. Knowing the background
morbidity of NAFLD in this highly pressured population
is important. In addition, the complete spectrum of
demographic and biological markers which may be
related to NAFLD should also be explored. Some uncer-
tainty still exists regarding the prevalence of and the
associated risk factors for NAFLD, in terms of gender
differences. This study was designed to clarify these
relationships.
Methods
Data resource and data collection
Company-employed or self-employed taxi drivers were
the targeted population. This cross-sectional study was
conducted between January 2006 and December 2006
with 1635 taxi drivers (1541 males and 94 females)
voluntarily admitted to one teaching hospital in north-
ern Taiwan for an annual physical check-up. Blood sam-
p l e sa n du l t r a s o u n ds o n o g r a phy results were collected.
Clinical nurses drew fasting blood samples via venipunc-
ture from the study participants. Overnight-fasting
serum and plasma samples (from whole blood preserved
with EDTA and NaF) were kept frozen (-20°C) until
ready for analysis. Disease or conditions were defined by
certain standards as follows: high fasting plasma glucose
(FPG)≥110 mg/dl, obesity: a body mass index (BMI)≥27
Kg/m
2, hypertension: a high systolic blood pressure
(SBP) ≥140 mmHg or high diastolic blood pressure
(DBP) ≥90 mmHg, hypercholesterolemia (≥200 mg/dL),
hypertriglyceridemia (≥200 mg/dL), and hyperuricemia
(≥7 mg/dL for males or ≥6 mg/dL for females). A serum
ALT or AST level ≥40 U/L was classified as elevated [6].
Ultrasound examination
Hepatic ultrasonography for all study participants was
performed by the well-trained ultrasonographist using a
Toshiba Nemio (SSA-550A) ultrasound probe. The
ultrasonographic criteria which were used to diagnose a
fatty liver included liver and kidney echo discrepancy,
presence of an increased liver echogenicity, echo pene-
tration into the deep portion of the liver, and clarity of
the liver blood vessel structures [7]. The definition of
NAFLD remains clinicopathological with well-defined
criteria of the patterns of liver injury [8,9]. For the
operational purposes of this study, the definition of
NAFLD used surrogate indicators of the disease, that is,
hepatic steatosis in persons who have negative serologic
tests for viral hepatitis, autoimmune liver disease, and
congenital causes of chronic hepatitis[8]. All study sub-
jects who were diagnosed as NAFLD at outpatient
department by ultrasound and without history of
chronic hepatitis and alcohol consumption were
enrolled the study. In addition, the degree of NAFLD on
ultrasonography was divided into mild and severe cases.
Interobserver reliability in ultrasound sonography
To establish a consistent diagnosis of NAFLD between
specialists, the Kappa statistic was used to assess the
agreement of inter-observer reliability among specialists
in this study. A pilot study was performed using 100
randomly selected healthy subjects other than the study
participants. For inter-observer reliability, the Kappa
value for diagnosis of NAFLDS between specialists was
0.78 (95%CI: 0.70-0.85).
Statistical analysis
Statistical analysis was performed using SAS for Win-
dows, (SAS version 9.1; SAS Institute Inc., Cary, NC,
USA). A p-value of <0.05 was considered to represent a
statistically significant difference between the two test
populations. For univariate analysis, the two-sample,
independent t-test method was adopted to assess differ-
ences in the mean value of continuous variables between
subjects with and without NAFLD. Crude and adjusted
odds ratios (adjustment for gender and age) were esti-
mated and 95% confidence intervals were used. Multiple
logistic regression was also performed to investigate the
independence of risk factors associated with the preva-
lence of NAFLD.
Results
Table 1 shows, the overall prevalence of NAFLD for the
screened population was 66.4%. The c
2 trend test
revealed no statistically significant decrease with increas-
ing subject age (p = 0.58). The prevalence of NAFLD for
males proved to be significantly greater than it was for
females (respectively, 67.5% vs 47.9%, c
2 test = 16.44, p
< 0.001). In addition, after stratifying the data by age
into one of four broad (age) groups, males exhibited a
more-pronounced prevalence of NAFLD for all age
groups than females.
The c
2 trend test revealed a significant positive rela-
tionship with age (p = 0.01) for female study subjects
but not for males (p = 0.24).
Table 2 shows the results of the comparison of a vari-
ety of test characteristics and their potential association
with the specific (NAFLD) class value (yes or no) for the
taxi drivers. The two-sample independent t-test found
that SBP, DBP, BMI, uric acid, AST, ALT, total choles-
terol, triglyceride, and FPG were associated with
NAFLD. In addition to SBP, DBP, BMI, uric acid, AST,
ALT, total cholesterol, and triglyceride were significantly
associated with NAFLD in both in males and in females.
ALP was significantly related to NAFLD only for female
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NAFLD in males not in females. (Table 3)
Table 4 presents the crude and adjusted odds ratios
for the association between certain relevant associated
risk factors and NAFLD. Subjects with NAFLD had a
more-pronounced prevalence of hypertension (adjusted
OR = 2.26, 95%CI: 1.69-3.03), a higher BMI (adjusted
OR = 6.88, 95%CI: 5.46-8.66), more hyperuricemia
(adjusted OR = 3.08, 95%CI: 1.95-4.88), higher AST
(adjusted OR = 2.04, 95%CI: 1.33-3.13), higher ALT
(adjusted OR = 3.79, 95%CI: 2.82-5.10), more hypercho-
lesterolemia (adjusted OR = 1.31, 95%CI: 1.07-1.81),
more hypertriglyceridemia (adjusted OR = 4.16, 95%CI:
3.01-5.75), and higher FPG (adjusted OR = 3.11, 95%CI:
1.98-4.89) than subjects without NAFLD, subsequent to
adjustment for gender and age.
The effect of independent associated risk factors upon
NAFLD was examined using the multiple logistic regres-
sion model. Table 5 shows that, subsequent to adjust-
ment for confounding factors, the presence of
hypertension (yes vs. no, OR = 1.42, 95%CI: 1.02-1.98),
higher BMI (yes vs. no, OR = 1.45, 95%CI: 1.38-1.53),
hyperuricemia (yes vs. no, OR = 1.79, 95%CI: 1.07-3.00),
higher AST (yes vs. no, OR = 2.82, 95%CI: 1.27-4.35),
higher ALT (yes vs. no, OR = 2.95, 95%CI: 1.77-3.98),
hypertriglyceridemia (yes vs. no, OR = 2.29, 95%CI:
1.60-1.49), and higher FPG (yes vs. no, OR = 2.06, 95%
CI: 1.24-3.42) appeared significantly related to NAFLD.
Table 5 also shows differences in gender that were
revealed by the multiple logistic regression. For males,
the significant risk factors related to an NAFLD
included the presence of hypertension (yes vs. no, OR =
1.37, 95%CI: 1.04-1.93), a higher BMI (yes vs. no, OR =
1.44, 95%CI: 1.37-1.52), hyperuricemia (yes vs. no, OR =
1.73, 95%CI: 1.07-2.89), higher AST (yes vs. no, OR =
2.70, 95%CI: 1.43-5.00), higher ALT (yes vs. no, OR =
2.83, 95%CI: 1.86-4.30), hypertriglyceridemia (yes vs. no,
OR = 2.22, 95%CI: 1.54-3.20), and higher FPG (yes vs.
no, OR = 2.23, 95%CI: 1.31-3.79). For females only the
presence of a higher BMI (yes vs. no, OR = 1.73, 95%CI:
1.28-2.35) was associated with a risk for NAFLD.
Discussions
Prevalence of non-alcoholic fatty liver disease
One of the important benefits of screening programs for
NAFLD was that chronic liver disease was often diag-
nosed as a consequence, as such a screening test was
commonly included in the serum chemistry panels
Table 1 The gender and age specific prevalence of NAFLD among screened taxi drivers (n = 1635)
Male(n = 1541) Female(n = 94) Total(n = 1635)
Age
(yrs)
Screened
No
NAFLD
No
Prevalence
(%)
p-value
for trend
test
Screened
No
NAFLD
No
Prevalence
(%)
p-
valuefor
trend
test
Screened
No
NAFLD
No
Prevalence
(%)
p-value
for trend
test
20-39 172 112 65.1 7 2 28.6 179 114 63.7
40-49 538 381 70.8 0.24 33 10 30.3 0.01 571 391 68.5 0.58
50-59 696 457 65.7 50 32 64.0 746 489 65.5
≥60 135 90 66.7 4 1 25.0 139 91 65.5
Total 1541 1040 67.5 94 45 47.9 1635 1085 66.4
Table 2 Comparisons of characteristics of NAFLD among screened taxi drivers
NAFLD
No
(n = 550)
Yes
(n = 1085)
Total
(n = 1635)
p-value
Variables Mean ± SD Mean ± SD Mean ± SD
Age(yr) 49.71 ± 7.82 49.57 ± 7.60 49.62 ± 7.67 0.73
SBP(mmHg) 120.93 ± 15.43 127.81 ± 15.48 125.49 ± 15.80 <0.001
DBP(mmHg) 76.58 ± 10.18 81.82 ± 10.36 80.06 ± 10.59 <0.001
BMI(Kg/m
2) 23.28 ± 2.77 26.64 ± 3.41 25.51 ± 3.58 <0.001
Uric acid(mg/dl) 5.97 ± 1.32 6.85 ± 1.44 6.55 ± 1.46 <0.001
AST(U/L) 22.99 ± 13.83 26.70 ± 17.49 25.45 ± 16.44 <0.001
ALT(U/L) 26.95 ± 27.73 38.32 ± 32.56 34.50 ± 31.47 <0.001
Total cholesterol (mg/dl) 202.25 ± 35.84 208.63 ± 35.49 206.48 ± 35.73 <0.001
Triglyceride (mg/dl) 115.71 ± 85.18 192.67 ± 185.44 166.78 ± 163.02 <0.001
Fasting plasma glucose (mg/dl) 90.47 ± 15.12 97.48 ± 28.11 95.12 ± 24.74 <0.001
ALP(U/L) 150.07 ± 38.99 153.53 ± 37.77 152.36 ± 38.21 0.08
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cance of such results was often ignored when the
NAFLD was deemed a slight abnormality The point pre-
valence of NAFLD varies widely with the population and
the diagnosis criteria used[10,11]. Because of this, the
prevalence of ultrasound-defined NAFLD in Chinese
populations ranged from 1% to more than 30% [11-13].
Previous studies also showed the occupational differ-
ences in the prevalence of fatty liver disease. Such differ-
ences were highest in administrative officers and white
collars workers, followed by laborers, peasants, and
monks [11,14]. The prevalence of NAFLD for our study
population (66.4%) was much higher than that found in
a previous population-based study conducted on the
Table 3 Comparisons of characteristics of NAFLD stratified by gender among screened taxi drivers
Male(n = 1541) Female(n = 94)
With NAFLD Without NAFLD p-value With NAFLD Without NAFLD p-value
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Age(year) 49.51 ± 7.68 49.81 ± 7.84 0.48 50.89 ± 5.35 48.67 ± 7.59 0.10
SBP(mmHg) 128.17 ± 15.45 121.97 ± 15.14 <0.001 119.40 ± 13.81 110.22 ± 119.40 0.002
DBP(mmHg) 82.00 ± 10.41 77.22 ± 10.10 <0.001 77.60 ± 8.13 70.02 ± 8.48 <0.001
BMI(kg/m
2) 26.67 ± 3.40 23.38 ± 2.80 <0.001 25.88 ± 3.44 22.23 ± 2.12 <0.001
Uric acid(mg/dl) 6.90 ± 1.43 6.10 ± 1.29 <0.001 5.72 ± 1.20 4.66 ± 0.86 <0.001
AST(mg/dl) 26.47 ± 16.97 23.30 ± 14.34 <0.001 31.96 ± 26.57 19.84 ± 5.93 0.004
ALT(mg/dl) 38.36 ± 32.36 27.76 ± 28.74 <0.001 37.33 ± 37.13 18.71 ± 10.82 0.002
ALP (U/L) 153.06 ± 37.24 151.63 ± 38.24 0.490 164.36 ± 47.73 134.06 ± 43.26 0.002
Total cholesterol (mg/dl) 208.36 ± 35.60 203.29 ± 35.42 0.009 214.96 ± 32.45 191.55 ± 38.69 0.002
Triglyceride (mg/dl) 194.62 ± 188.56 118.23 ± 87.73 <0.001 147.56 ± 73.63 89.94 ± 45.52 <0.001
Fasting plasma glucose (mg/dl) 97.64 ± 28.55 90.51 ± 15.32 <0.001 93.89 ± 13.93 90.08 ± 13.10 0.18
Table 4 Crude and adjusted odds ratio of associated factors for NAFLD among screened taxi drivers
Item With NAFLD
(n = 1085)
Without NAFLD (n = 550) Crude odds ratio Adjusted odds ratio
1
Gender female 45 49 2.26 —
male 1040 501 (1.49-3.44) —
Age 20-39 114 65 1.00 —
40-49 391 180 0.93
(0.58-1.47)
—
50-59 489 257 1.15
(0.69-1.47)
≥60 91 48 1.00
(0.77-1.70)
—
Hypertension yes 824 487 2.28 2.26
no 261 67 (1.71-3.06) (1.69-3.03)
Higher BMI yes 865 200 6.96 6.88
no 217 349 (5.53-8.745) (5.46-8.66)
Hyperuricemia yes 956 527 3.07 3.08
no 128 23 (1.94-4.84) (1.95-4.88)
Higher AST yes 109 29 2.01 2.04
no 976 521 (1.31-3.06) (1.33-3.13)
Higher ALT yes 354 62 3.84 3.79
no 731 488 (2.84-5.11) (2.82-5.10)
Hyper-cholesterolemia yes 645 277 1.45 1.31
no 440 273 (1.18-1.78) (1.07-1.81)
Hyper-triglyceridemia yes 317 49 4.22 4.16
no 768 501 (3.06-5.18) (3.01-5.75)
Higher fasting plasma yes 133 24 3.06 3.11
glucose no 952 526 (1.96-4.79) (1.98-4.89)
1Aujestment for gender and age
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hard work, job stress, and a disruption in normal sleep
and waking pattern. An irregular lifestyle, eating habits
and sedentary work are also major problems. This might
partially explain the high prevalence of NAFLD observed
in our study.
The implications of gender difference as regards
associated factors for NAFLD
Ad e t a i l e da n a l y s i so ft h i ss c r e e n i n gd a t as h o w st h a t
associated factors for NAFLD in taxi drivers in Taiwan
resemble those in other population-based studies
[9,11-14]. Our results showed that male gender and an
older age are significant risk factors for NAFLD. Such a
finding would appear to be consistent with the results of
other population-based studies [7,8]. Previously pub-
lished studies emphasized that NAFLD was more com-
mon among females [15], however, recent results have
s h o w nt h a tN A F L Dm a yb em o r ep r e v a l e n ta m o n g
males [8]. Female hormones have been postulated to
protect against NAFLD. This is supported by evidence
that NAFLD is twice as common in postmenopausal
women as in premenopausal women [8,16]. In addition,
NAFLD appears to increase with age. Several academic
studies using different diagnostic methods had similar
findings [5,12-14].
Our results revealed that a higher FPG was associated
with NAFLD. Compared to non diabetic subjects, type 2
diabetics appear to have an increased risk of developing
NAFLD, fibrosis, and cirrhosis [17-19]. Among Chinese
with NAFLD and without type 2 diabetes in Hong
Kong, impaired glucose tolerance without elevation of
FPG is common and related to histologically severe liver
disease [20,21].
The history of chronic liver disease is usually long and
asymptomatic before the development of late-stage dis-
ease. The only markers of liver damage during this long
phase may be increased serum levels of enzymes such as
ALT, AST, and gamma-glutamyltransferase (GGT).
Decrease platelet counts and indexes of hepatic bio-
synthesis usually occur in advanced stages of chronic
liver disease [22]. Increasing evidence indicates that sig-
nificant liver disease may accompany seemingly mild
serum aminotransferase level elevations [6]. Consistent
with the results of other studies [11], our results
revealed that a higher ALT was associated with NAFLD.
The determination of the serum ALT level constitutes
the most-frequently applied test for the identification of
patients suffering from liver disease. This parameter also
acts as a surrogate marker for disease severity and/or an
index of hepatic activity [23]. The prevalence of fatty
liver disease in patients with elevated ALT increased
from 26% to 51% in the studied population [11,24]. In
mainland China and Taiwan, NAFLD is becoming one
of major causes of asymptomatic elevation of liver
enzymes [24,25].
Hypertension, higher fasting plasma glucose, and
hypertriglyceridemia, were significantly related to
NAFLD in this study. The well established term ‘meta-
bolic syndrome’ remains the most useful and widely
accepted description of this cluster of metabolically
related cardiovascular risk factors which also predict a
high risk of developing diabetes[26]. A long-term fol-
low-up study demonstrated that the presence of meta-
bolic syndrome was associated with an increased risk
of NAFLD [27]. Metabolic syndrome can be viewed as
a strong predictor of NAFLD and NAFLD can be
viewed as a good predictor for the clustering of com-
ponents of risk factors for metabolic syndrome [21-23].
BMI and waist circumference are also good predictors
of NAFLD [11]. In our study, the presence of a higher
BMI was associated with a higher risk for NAFLD
even after adjusting for other confounding factors.
Using the Western criteria for obesity, only 2-3% Asia
subjects can be identified as obese [11]. Asians have a
higher proportion of visceral fat and a lower propor-
tion of lean body mass than Caucasians with the same
BMI condition [28].
Table 5 Multiple logistic regression of associated factors for NAFLD among screened taxi drivers
Male (n = 1541) Female (n = 94) Total(n = 1 635)
OR 95%CI OR 95%CI OR 95%CI
Gender(male vsfemale) ———— 1.28 0.78-2.11
Age(yrs) 1.01 0.98-1.02 1.03 0.94-1.13 1.02 0.97-1.04
Hypertension (yes vs no) 1.37 1.04-1.93 2.84 0.45-8.56 1.42 1.02-1.98
Higher BMI(yesvs no) 1.44 1.37-1.52 1.73 1.28-2.35 1.45 1.38-1.53
Hyperuricemia (yes vs no) 1.73 1.07-2.89 —— 1.79 1.07-3.00
Higher AST (yesvs no) 2.70 1.43-5.00 12.38 0.15-22.04 2.82 1.27-4.35
Higher ALT(yesvs no) 2.83 1.86-4.30 3.23 0.03-4.90 2.95 1.77-3.98
Hypercholesterolemia (yes vs no) 1.10 0.85-1.41 2.37 0.76-7.40 1.16 0.91-1.49
Hypertriglyceridemia(yes vs no) 2.22 1.54-3.20 2.92 0.24-36.07 2.29 1.60-3.28
Higher fasting plasma glucose (yes vs no) 2.23 1.31-3.79 2.70 0.66-4.07 2.06 1.24-3.42
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related to males with NAFLD. Clinical studies have
shown that a fructose load might lead to a more-sub-
stantial increase in serum uric-acid levels among
patients suffering chronic hepatitis than in normal sub-
jects [29]. Serum uric-acid levels have been reported ele-
vated among subjects suffering from chronic liver
lesions, especially those of a non-infectious origin [6].
Furthermore, the extent of such serum-level elevation
appears to be dependent upon the specific severity of
the hepatic lesions [6,30]. We were not able to deter-
mine the degree of serum uric acid level increase prior
to the development of liver disease having developed
because of the cross-sectional nature of our study.
Further epidemiological and etiological investigations
are needed to clarify the pathophysiological mechanisms
relating gender differences with uric acid and NAFLD.
Perceived limitations
One of major limitations of this study was potential
selection bias due to the screening of taxi drivers from
one area. The potential impact on the prevalence and the
study-observed NAFLD-associated risk factors were, in
our estimation, inevitable. Nevertheless, given the rather
l a r g es a m p l es i z e ,t h es t u d yr e tained sufficient statistical
power to evaluate the presence of any gender differences
among the various risk factors for NAFLD. Secondly,
because no standard diagnostic elevation has been inter-
nationally accepted for defining NAFLD, different studies
may elect to set slightly different definitions, such that
our estimation of what constituted NAFLD could have
suffered from some level of misclassification-bias. This is
because ultrasound has limited sensitivity when the
degree of steatosis is less than 30% and it is considered
highly operator-dependent [8,31]. Thirdly, in considera-
tion of costs, we did not collect information from liver
biopsies to confirm, diagnose, and determine the stage of
NAFLD. Fourthly, a gender bias may exist since fewer
female taxi drivers were a part of our study. Although
group sample sizes of 1541 males and 94 females group
achieved 97% power to detect difference in NAFLD pre-
valence between male and females [32,33], a bias esti-
mated is still might have occurred. Finally, our
measurements were conducted at only a single point in
time and, therefore, may not reflect long-term exposure
to important demographic or biochemical factors. The
solution to such a quandary would be to conduct a num-
ber of prospective longitudinal analogous studies to see if
they would complement the community-based (cross-
sectional) findings of this study.
Conclusions
This study found several gender-related dissimilarities
regarding the relationship of hyperuricemia, higher AST,
higher ALT, hypertriglyceridemia, and higher fasting
plasma glucose with NAFLD. Further studies are needed
to elucidate the temporal sequence of events that typi-
cally lead to NAFLD. Such studies would develop more-
satisfactory, non-invasive indicators of liver pathology
and assess how gender-related differences are related
NAFLD.
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